218 related articles for article (PubMed ID: 35109759)
1. Impact of
Bailey BA; Shah DS; Boynewicz KL; Justice NA; Wood DL
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9383-9390. PubMed ID: 35109759
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
3. Trajectories of Prescription Opioid Utilization During Pregnancy Among Prepregnancy Chronic Users and Risk of Neonatal Opioid Withdrawal Syndrome.
Straub L; Huybrechts KF; Hernández-Díaz S; Zhu Y; Vine S; Desai RJ; Gray KJ; Bateman BT
Am J Epidemiol; 2022 Jan; 191(1):208-219. PubMed ID: 34643225
[TBL] [Abstract][Full Text] [Related]
4. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
[TBL] [Abstract][Full Text] [Related]
5. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
[TBL] [Abstract][Full Text] [Related]
6. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
[TBL] [Abstract][Full Text] [Related]
7. Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population.
Azuine RE; Ji Y; Chang HY; Kim Y; Ji H; DiBari J; Hong X; Wang G; Singh GK; Pearson C; Zuckerman B; Surkan PJ; Wang X
JAMA Netw Open; 2019 Jun; 2(6):e196405. PubMed ID: 31251378
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A
J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916
[TBL] [Abstract][Full Text] [Related]
9. A Practical Approach to Neonatal Opiate Withdrawal Syndrome.
Devlin LA; Davis JM
Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261
[TBL] [Abstract][Full Text] [Related]
10. The Negative Impact of Maternal Perinatal Opioid Use on Neonatal Outcomes.
Gandhi KD; Schak KM; Vande JL; Shekunov J; Lynch BA; Rummans TA; Geske JR; Pease ER; Limbeck MG; Desai J; Croarkin PE; Romanowicz M
Prim Care Companion CNS Disord; 2021 Jun; 23(3):. PubMed ID: 34115451
[No Abstract] [Full Text] [Related]
11. Neonatal abstinence syndrome.
Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE
Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370
[TBL] [Abstract][Full Text] [Related]
12. Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome.
Wang Y; Berger L; Durrance C; Kirby RS; Kuo D; Pac J; Ehrenthal DB
Obstet Gynecol; 2023 Sep; 142(3):603-611. PubMed ID: 37548391
[TBL] [Abstract][Full Text] [Related]
13. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E
BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628
[No Abstract] [Full Text] [Related]
14. The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome.
Devlin LA; Hu Z; Ounpraseuth S; Simon AE; Annett RD; Das A; Fuller JF; Higgins RD; Merhar SL; Smith PB; Crawford MM; Cottrell LE; Czynski AJ; Newman S; Paul DA; Sánchez PJ; Semmens EO; Smith MC; Whalen BL; Snowden JN; Young LW;
Matern Child Health J; 2023 Jun; 27(6):1030-1042. PubMed ID: 36905529
[TBL] [Abstract][Full Text] [Related]
15. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
[No Abstract] [Full Text] [Related]
16. Delivery timing for the opioid-exposed infant.
Sanusi A; Gray M; Xue Y; Mohr S; Curtis P; Dismukes J; Gentle S; Szychowski JM; Brocato B; Casey B; Harper L; Sinkey R
Am J Obstet Gynecol MFM; 2022 Nov; 4(6):100719. PubMed ID: 35977700
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.
Kelty E; Preen DB
CNS Drugs; 2019 Nov; 33(11):1113-1120. PubMed ID: 31686408
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
[TBL] [Abstract][Full Text] [Related]
19. Opioids affect the fetal brain: reframing the detoxification debate.
Caritis SN; Panigrahy A
Am J Obstet Gynecol; 2019 Dec; 221(6):602-608. PubMed ID: 31323217
[TBL] [Abstract][Full Text] [Related]
20. Impact of In-utero Exposure to Selective Serotonin Reuptake Inhibitors and Opioids on Neonatal Opioid Withdrawal Syndrome.
Bhatt-Mehta V; Richards J; Sturza J; Schumacher RE
J Addict Med; 2019; 13(3):227-234. PubMed ID: 30489344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
